Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katharina Fink

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Neurodegenerative Disease Management|November 23, 2016
Multiple sclerosis e-registriesKatharina Fink
BMJ Open|January 14, 2025
Workplace and social support, treatment satisfaction, and their impact on quality of life in Swedish women with multiple sclerosis: a cross-sectional survey studyAlejandra Machado, Elin Wredendal, Katharina Fink, et al.
Healthcare (Basel, Switzerland)|August 9, 2024
Oral Health-Related Quality of Life among Refugees: A Questionnaire-Based StudyKatharina Fink, Kais Alkayed, Franz Sebastian Schwindling, et al.
Multiple Sclerosis and Related Disorders|November 5, 2019
Interrupting rituximab treatment in relapsing-remitting multiple sclerosis; no evidence of rebound disease activityAlexander Juto, Katharina Fink, Faiez Al Nimer, et al.
Neurobiology of Disease|September 23, 2006
Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areasRainer Hellweg, Maha Zueger, Katharina Fink, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 14, 2016
A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort studyHelga Westerlind, Leszek Stawiarz, Katharina Fink, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2016
Re: Declines in the diagnosis of primary progressive MS-A critical change in phenotype or critical measurement error?Helga Westerlind, Leszek Stawiarz, Katharina Fink, et al.
Psychiatry and Clinical Neurosciences|July 23, 2014
Successful treatment of excessive supragastric belching by combination of pregabalin and baclofenHagen Kunte, Golo Kronenberg, Katharina Fink, et al.
Archives of Physical Medicine and Rehabilitation|February 7, 2018
Predictors for Employment Status in People With Multiple Sclerosis: A 10-Year Longitudinal Observational StudyMia Forslin, Katharina Fink, Ulf Hammar, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2026
Treatment persistence in paediatric-onset multiple sclerosis: A Swedish nationwide registry studyFredrik Sandesjö, Kyla A McKay, Katharina Fink, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Neurodegenerative Disease Management|November 23, 2016
Multiple sclerosis e-registriesKatharina Fink
BMJ Open|January 14, 2025
Workplace and social support, treatment satisfaction, and their impact on quality of life in Swedish women with multiple sclerosis: a cross-sectional survey studyAlejandra Machado, Elin Wredendal, Katharina Fink, et al.
Healthcare (Basel, Switzerland)|August 9, 2024
Oral Health-Related Quality of Life among Refugees: A Questionnaire-Based StudyKatharina Fink, Kais Alkayed, Franz Sebastian Schwindling, et al.
Multiple Sclerosis and Related Disorders|November 5, 2019
Interrupting rituximab treatment in relapsing-remitting multiple sclerosis; no evidence of rebound disease activityAlexander Juto, Katharina Fink, Faiez Al Nimer, et al.
Neurobiology of Disease|September 23, 2006
Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areasRainer Hellweg, Maha Zueger, Katharina Fink, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 14, 2016
A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort studyHelga Westerlind, Leszek Stawiarz, Katharina Fink, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2016
Re: Declines in the diagnosis of primary progressive MS-A critical change in phenotype or critical measurement error?Helga Westerlind, Leszek Stawiarz, Katharina Fink, et al.
Psychiatry and Clinical Neurosciences|July 23, 2014
Successful treatment of excessive supragastric belching by combination of pregabalin and baclofenHagen Kunte, Golo Kronenberg, Katharina Fink, et al.
Archives of Physical Medicine and Rehabilitation|February 7, 2018
Predictors for Employment Status in People With Multiple Sclerosis: A 10-Year Longitudinal Observational StudyMia Forslin, Katharina Fink, Ulf Hammar, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 31, 2026
Treatment persistence in paediatric-onset multiple sclerosis: A Swedish nationwide registry studyFredrik Sandesjö, Kyla A McKay, Katharina Fink, et al.
Pageof 8